{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:24:32Z","timestamp":1793042672489,"version":"4.5.0"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jcrs.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T10:17:45Z","timestamp":1491905865000},"page":"405-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Surgical techniques and adjuvants for the management of primary and recurrent pterygia"],"prefix":"10.1097","volume":"43","author":[{"given":"John A.","family":"Hovanesian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Vroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.P.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Shamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/ICO.0000000000000097","article-title":"Seasonal effects on pterygium surgery outcome: implications for the role of sunlight exposure.","volume":"33","author":"Sul","year":"2014","journal-title":"Cornea"},{"issue":"9","key":"R2-20-20210210","first-page":"e30","article-title":"Risk factors associated with pterygium and its subtypes in Korea: the Korean National Health and Nutrition Examination Survey 2008-2010. Cornea. 2013;32:962-970.","volume":"35","author":"Rim","year":"2016","journal-title":"erratum"},{"key":"R5-20-20210210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1039\/c0pp90044c","article-title":"The human health effects of ozone depletion and interactions with climate change.","volume":"10","author":"Norval","year":"2011","journal-title":"Photochem Photobiol Sci"},{"key":"R10-20-20210210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1542-0124(12)70103-9","article-title":"The pathogenesis of pterygium: current concepts and their therapeutic implications.","volume":"6","author":"Chui","year":"2008","journal-title":"Ocular Surf"},{"key":"R11-20-20210210","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00055735-199908000-00011","article-title":"The pathogenesis of pterygia.","volume":"10","author":"Coroneo","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"R12-20-20210210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2004.02.002","article-title":"Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases.","volume":"23","author":"Di Girolamo","year":"2004","journal-title":"Prog Retin Eye Res"},{"issue":"Suppl 1","key":"R15-20-20210210","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1442-9071.1998.tb01362.x","article-title":"Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study.","volume":"26","author":"Panchapakesan","year":"1998","journal-title":"Aust N Z J Ophthalmol"},{"key":"R18-20-20210210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICU.0b013e3281a7ecbb","article-title":"Current concepts and techniques in pterygium treatment.","volume":"18","author":"Ang","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R19-20-20210210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/opep.6.3.219.1504","article-title":"Pterygium: prevalence, demography and risk factors.","volume":"6","author":"Saw","year":"1999","journal-title":"Ophthalmic Epidemiol"},{"key":"R20-20-20210210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9394(00)00703-0","article-title":"The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey.","volume":"131","author":"Wong","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R24-20-20210210","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/02713683.2013.823212","article-title":"Progress in the pathogenesis of pterygium.","volume":"38","author":"Liu","year":"2013","journal-title":"Curr Eye Res"},{"key":"R25-20-20210210","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1442-9071.2001.d01-21.x","article-title":"Pterygium in Australia: a cost of illness study.","volume":"29","author":"Wlodarczyk","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"R26-20-20210210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(14)72602-9","article-title":"A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium.","volume":"120","author":"Chen","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R28-20-20210210","first-page":"463","article-title":"Vorhersage von Pterygiumrezidiven aufgrund morphologischer und immunhistologischer Parameter.","volume":"92","author":"Rohrbach","year":"1995","journal-title":"Predicting recurrent pterygium based on morphologic and immunohistologic parameters, Ophthalmologe"},{"key":"R29-20-20210210","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archopht.1997.01100160405001","article-title":"Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision.","volume":"115","author":"Tan","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R31-20-20210210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0b013e3181b11630","article-title":"Comparison of pterygium recurrence rates in Hispanic and white patients after primary excision and conjunctival autograft.","volume":"29","author":"Kandavel","year":"2010","journal-title":"Cornea"},{"key":"R38-20-20210210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jama.1902.52480320006001b","article-title":"The nature and treatment of pterygia.","volume":"39","author":"McReynolds","year":"1902","journal-title":"JAMA"},{"key":"R41-20-20210210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0039-6257(02)00463-0","article-title":"The treatment of pterygium.","volume":"48","author":"Hirst","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"R43-20-20210210","first-page":"96","article-title":"Etude comparative du Thio-tepa et de la Mitomycine C dans le traitement du pterygion. Resultats preliminaires. A comparative study of thio-tepa and mitomycin C in the treatment of pterygium.","volume":"21","author":"Ngoy","year":"1998","journal-title":"Preliminary results, J Fr Ophtalmol"},{"key":"R44-20-20210210","first-page":"215","article-title":"Collyre thiotepa pour prevenir les recidives des pterygions; 18 ans dutilisation. Thiotepa eyedrops for prevention of pterygium recurrence: 18 years of use, J Fr O","volume":"22","author":"Tassy","year":"1999","journal-title":"phtalmol"},{"key":"R45-20-20210210","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archopht.1977.04450080135017","article-title":"Conjunctival transplantation.","volume":"95","author":"Thoft","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"R46-20-20210210","first-page":"19","article-title":"Zur Operation des Pterygium und zur Transplantation von Schleimhaut.","volume":"21","author":"Klein","year":"1876","journal-title":"Allg Wein med Ztg"},{"key":"R49-20-20210210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-5223(19)35324-3","article-title":"Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations: a multicenter study.","volume":"97","author":"Rousou","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R51-20-20210210","first-page":"90","article-title":"Fibrin fixation of skin transplant.","volume":"15","author":"Tidrick","year":"1944","journal-title":"Surgery"},{"key":"R56-20-20210210","first-page":"221","article-title":"The current status of cyanoacrylate and fibrin tissue adhesives.","volume":"2","author":"Forseth","year":"1992","journal-title":"J Long Term Eff Med Implants"},{"key":"R58-20-20210210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/ICO.0b013e318183a362","article-title":"Pterygium recurrence after excision with conjunctival autograft: a comparison of fibrin tissue adhesive to absorbable sutures.","volume":"28","author":"Farid","year":"2009","journal-title":"Cornea"},{"key":"R59-20-20210210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/ajot.2001.24817","article-title":"Safety and efficacy of currently available fibrin tissue adhesives.","volume":"22","author":"Siedentop","year":"2001","journal-title":"Am J Otolaryngol"},{"key":"R60-20-20210210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0140-6736(93)91273-O","article-title":"Solventdetergent-treated clotting factors and hepatitis A virus seroconversion letter.","volume":"341","author":"Evensen","year":"1993","journal-title":"Lancet"},{"key":"R61-20-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(94)90993-8","article-title":"B19 parvovirus DNA in solventdetergent-treated anti-haemophilia concentrates.","volume":"343","author":"Lefrere","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"R63-20-20210210","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.tripleo.2005.07.008","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution.","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R64-20-20210210","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.thromres.2007.12.027","article-title":"Large-scale preparation of thrombin from human plasma.","volume":"122","author":"Aizawa","year":"2008","journal-title":"Thromb Res"},{"key":"R65-20-20210210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2007.08.006","article-title":"In vivo efficacy of a new autologous fibrin sealant.","volume":"146","author":"Alston","year":"2008","journal-title":"J Surg Res"},{"key":"R67-20-20210210","first-page":"1606","article-title":"Anaphylactic reaction to aprotinin following topical use of biological tissue sealant Japanese M","volume":"43","author":"Kon","year":"1994","journal-title":"asui"},{"key":"R68-20-20210210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1537-2995.2000.40030302.x","article-title":"An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant.","volume":"40","author":"Beierlein","year":"2000","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"R69-20-20210210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0967-2109(03)00068-1","article-title":"The safety of fibrin sealants.","volume":"11","author":"Joch","year":"2003","journal-title":"Cardiovasc Surg"},{"key":"R70-20-20210210","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1537-2995.2008.01717.x","article-title":"Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin.","volume":"48","author":"Horowitz","year":"2008","journal-title":"Transfusion"},{"key":"R72-20-20210210","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/ja01573a087","article-title":"The synthesis of 5-fluoropyrimidines letter.","volume":"79","author":"Duschinsky","year":"1957","journal-title":"J Am Chem Soc"},{"key":"R73-20-20210210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9394(14)72957-5","article-title":"Comparative toxicity of mitomycin C and 5-fluorouracil in vitro.","volume":"118","author":"Smith","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R76-20-20210210","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00003226-200308000-00007","article-title":"5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report.","volume":"22","author":"Akarsu","year":"2003","journal-title":"Cornea"},{"key":"R77-20-20210210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003226-200103000-00011","article-title":"Halting pterygium recurrence by postoperative 5-fluorouracil.","volume":"20","author":"Pikkel","year":"2001","journal-title":"Cornea"},{"key":"R78-20-20210210","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2006.02.026","article-title":"Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.","volume":"113","author":"Prabhasawat","year":"2006","journal-title":"Ophthalmology"},{"key":"R79-20-20210210","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0161-6420(97)30197-3","article-title":"Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.","volume":"104","author":"Prabhasawat","year":"1997","journal-title":"Ophthalmology"},{"key":"R80-20-20210210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00003226-199010000-00011","article-title":"Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation.","volume":"9","author":"Singh","year":"1990","journal-title":"Cornea"},{"key":"R81-20-20210210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0002-9394(88)90706-4","article-title":"Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium.","volume":"106","author":"Hayasaka","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R82-20-20210210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00003226-199409000-00006","article-title":"Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report.","volume":"13","author":"Frucht-Pery","year":"1994","journal-title":"Cornea"},{"key":"R83-20-20210210","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0161-6420(95)30770-1","article-title":"Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery.","volume":"102","author":"Cardillo","year":"1995","journal-title":"Ophthalmology"},{"key":"R84-20-20210210","first-page":"575","article-title":"Bilateral cicatricial ectropion following topical administration of 5-fluorouracil.","volume":"13","author":"Galentine","year":"1981","journal-title":"Ann Ophthalmol"},{"key":"R85-20-20210210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archopht.1981.03930010286013","article-title":"Punctal-canalicular stenosis related to systemic fluorouracil therapy.","volume":"99","author":"Caravella","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"R87-20-20210210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0161-6420(87)33430-X","article-title":"Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects.","volume":"94","author":"Weinreb","year":"1987","journal-title":"Ophthalmology"},{"key":"R88-20-20210210","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0161-6420(94)31269-3","article-title":"The use of low-dose mitomycin C for prevention of recurrent pterygium.","volume":"101","author":"Frucht-Pery","year":"1994","journal-title":"Ophthalmology"},{"key":"R90-20-20210210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00003226-199609000-00015","article-title":"Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C.","volume":"15","author":"Dougherty","year":"1996","journal-title":"Cornea"},{"key":"R95-20-20210210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1002423621010","article-title":"Human amniotic membrane in the reconstruction of the ocular surface.","volume":"98","author":"Gabric","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"R96-20-20210210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9394(14)71693-9","article-title":"Amniotic membrane transplantation for conjunctival surface reconstruction.","volume":"124","author":"Tseng","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R98-20-20210210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10353-004-0115-2","article-title":"Optimized thrombin dilution protocol for a slowly setting fibrin sealant in surgery.","volume":"37","author":"Goessl","year":"2005","journal-title":"Eur Surg"},{"key":"R99-20-20210210","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0161-6420(02)01160-0","article-title":"Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium.","volume":"109","author":"Al Fayez","year":"2002","journal-title":"Ophthalmology"},{"key":"R100-20-20210210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archophthalmol.2012.2599","article-title":"Limbal-conjunctival vs conjunctival autograft transplant for recurrent pterygia: a prospective randomized controlled trial.","volume":"131","author":"Al Fayez","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R102-20-20210210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00003226-199105000-00002","article-title":"Conjunctival autograft for primary and recurrent pterygia: surgical technique and problem management.","volume":"10","author":"Starck","year":"1991","journal-title":"Cornea"},{"key":"R104-20-20210210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0161-6420(02)01453-7","article-title":"Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium.","volume":"110","author":"Shimazaki","year":"2003","journal-title":"Ophthalmology"},{"key":"R105-20-20210210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcjo.2016.02.022","article-title":"Pterygium excision with conjunctival autograft and subconjunctival amniotic membrane as antirecurrence agents.","volume":"51","author":"Shusko","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"R107-20-20210210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713680903395273","article-title":"Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.","volume":"35","author":"Fallah","year":"2010","journal-title":"Curr Eye Res"},{"key":"R108-20-20210210","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijrobp.2003.12.021","article-title":"Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial.","volume":"59","author":"Jurgenliemk-Schulz","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R109-20-20210210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/112067219600600307","article-title":"Instillation of mitomycin C after recurrent pterygium surgery.","volume":"6","author":"Kraut","year":"1996","journal-title":"Eur J Ophthalmol"},{"key":"R114-20-20210210","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","article-title":"Serious complications of topical mitomycin-C after pterygium surgery.","volume":"99","author":"Rubinfeld","year":"1992","journal-title":"Ophthalmology"},{"key":"R117-20-20210210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0161-6420(94)31270-X","article-title":"Pterygium recurrence time.","volume":"101","author":"Hirst","year":"1994","journal-title":"Ophthalmology"},{"key":"R118-20-20210210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0002-9394(98)00327-4","article-title":"Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.","volume":"127","author":"Frucht-Pery","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R119-20-20210210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000151740","article-title":"Topical cyclosporine A in the prevention of pterygium recurrence.","volume":"222","author":"Yalcin Tok","year":"2008","journal-title":"Ophthalmologica"},{"key":"R121-20-20210210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0008-4182(05)80031-6","article-title":"Treatment of early pterygium recurrence with topical administration of interferon alpha-2b.","volume":"40","author":"Esquenazi","year":"2005","journal-title":"Can J Ophthalmol"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335017301086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335017301086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2017.03.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:29:18Z","timestamp":1623781758000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02158034-201703000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2017.03.002","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical techniques and adjuvants for the management of primary and recurrent pterygia","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASCRS and ESCRS Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}